Glenmark
Pharma stocks rally 14% on US tariff exemption; Gland, Aurobindo Pharma lead gains
Domestic formulations biz expected to grow 9-10% over next decade: Glenmark
Glenmark unit ties up with BeiGene to market cancer drugs in India